0001127602-23-012013.txt : 20230404
0001127602-23-012013.hdr.sgml : 20230404
20230404063053
ACCESSION NUMBER: 0001127602-23-012013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Theagene Jean-Manasse
CENTRAL INDEX KEY: 0001969857
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 23795043
MAIL ADDRESS:
STREET 1: 500 PLACE D ARMES
STREET 2: SUITE 1800
CITY: MONTREAL
STATE: A8
ZIP: H2Y 2W2
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-03-31
0001878313
MAIA Biotechnology, Inc.
MAIA
0001969857
Theagene Jean-Manasse
444 WEST LAKE STREET, SUITE 1700
CHICAGO
IL
60606
1
0
Stock Options
3.46
2023-03-31
4
A
0
945
0
A
2023-03-31
2033-03-31
Common Stock
945
945
D
The stock options, granted on March 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
/s/ Jean-Manasse Theagene
2023-04-04